Phosphorylation of the α4 subunit of human α4β2 nicotinic receptors: Role of cAMP-dependent protein kinase (PKA) and protein kinase C (PKC)

Molecular Brain Research

Volumn 114, Issue 1, 2003, Pages 65-72

  Pacheco, Mary A ^a   Pastoor, Tina E ^a   Wecker, Lynn ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Cyclic AMP dependent protein kinase; Human 4 2 neuronal nicotinic receptors; Phosphorylation; Protein kinase C

Indexed keywords

2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; ADENOSINE TRIPHOSPHATE; BUCLADESINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DERIVATIVE; FORSKOLIN; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; NICOTINIC RECEPTOR; PHOSPHATE; PROTEIN KINASE C; PROTEIN SUBUNIT; 8 BROMO CYCLIC AMP; 8 BROMOADENOSINE 3',5' CYCLIC MONOPHOSPHOROTHIOATE; 8-BROMOADENOSINE-3',5'-CYCLIC MONOPHOSPHOROTHIOATE; CARCINOGEN; DRUG DERIVATIVE; ENZYME INHIBITOR; INDOLE DERIVATIVE; ISOQUINOLINE DERIVATIVE; NICOTINIC ACETYLCHOLINE RECEPTOR ALPHA4 SUBUNIT; NICOTINIC RECEPTOR ALPHA4BETA2; NUCLEOTIDE; PHORBOL 13 ACETATE 12 MYRISTATE; RO 31-8220; SULFONAMIDE;

ARTICLE; AUTORADIOGRAPHY; CELL LABELING; DRUG EFFECT; EPITHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; CELL LINE; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; METABOLISM; NERVE CELL; PHOSPHORYLATION;

TRIXIS;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; BUCLADESINE; CARCINOGENS; CELL LINE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME INHIBITORS; FORSKOLIN; HUMANS; INDOLES; ISOQUINOLINES; NEURONS; PHOSPHORYLATION; PROTEIN KINASE C; RECEPTORS, NICOTINIC; SULFONAMIDES; TETRADECANOYLPHORBOL ACETATE; THIONUCLEOTIDES; TRANSFECTION;

EID: 0038356890     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(03)00138-4     Document Type: Article

References (29)

1. Blom N., Gammeltoft S., Brunak S. Sequence- and structure-based prediction of eukaryotic protein phosphorylation sites. J. Mol. Biol. 294:1999;1351-1362.
2. Buisson B., Bertrand D. Chronic exposure to nicotine upregulates the human α4β2 nicotinic acetylcholine receptor function. J. Neurosci. 21:2001;1819-1829.
3. Covernton P.J., Connolly J.G. Multiple components in the agonist concentration-response relationships of neuronal nicotinic acetylcholine receptors. J. Neurosci. Methods. 96:2000;63-70.
4. Davis P.D., Elliott L.H., Harris W., Hill C.H., Hurst S.A., Keech E., Hari Kumar M.K., Lawton G., Nixon J.S., Wilkinson S.E. Inhibitors of protein kinase C. 2. Substituted bisindolylmaleimides with improved potency and selectivity. J. Med. Chem. 35:1992;994-1001.
5. Eilers H., Schaeffer E., Bickler P.E., Forsayeth J.R. Functional deactivation of the major neuronal nicotinic receptor caused by nicotine and a protein kinase C-dependent mechanism. Mol. Pharmacol. 52:1997;1105-1112.
6. Fenster C.P., Beckman M.L., Parker J.C., Sheffield E.B., Whitworth T.L., Quick M.W., Lester R.A.J. Regulation of α4β2 nicotinic receptor desensitization by calcium and protein kinase C. Mol. Pharmacol. 55:1999;432-443.
7. Gentry C.L., Wilkins L.H. Jr., Lukas R.J. Effects of prolonged nicotinic ligand exposure on function of heterologously expressed human α4β2- and α4β4-nicotinic acetylcholine receptors. J. Pharmacol. Exp. Ther. 304:2003;206-216.
8. Gopalakrishnan M., Molinari E.J., Sullivan J.P. Regulation of human α4β2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways. Mol. Pharmacol. 52:1997;524-534.
9. Guo X., Wecker L. Identification of three cAMP-dependent protein kinase (PKA) phosphorylation sites within the major intracellular domain of neuronal nicotinic receptor α4 subunits. J. Neurochem. 82:2002;439-447.
10. Hsu Y.-N., Amin J., Weiss D.S., Wecker L. Sustained nicotine exposure differentially affects α3β2 and α4β2 neuronal nicotinic receptors expressed in Xenopus oocytes. J. Neurochem. 66:1996;667-675.
11. Hsu Y.-N., Edwards S.C., Wecker L. Nicotine enhances the cyclic AMP-dependent protein kinase-mediated phosphorylation of α4 subunits of neuronal nicotinic receptors. J. Neurochem. 69:1997;2427-2431.
12. Jeanclos E.M., Lin L., Treuil M.W., Rao J., DeCoster M.A., Anand R. The chaperone protein 14-3-3η interacts with the nicotinic acetylcholine receptor α4 subunit. J. Biol. Chem. 276:2001;28281-28290.
13. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
14. 3H]forskolin. Methods Enzymol. 195:1991;52-65.
15. Levitan I.B. Modulation of ion channels by protein phosphorylation - how the brain works. Adv. Second Messenger Phosphoprotein Res. 33:1999;3-22.
16. Miles K., Anthony D.T., Rubin L.L., Greengard P., Huganir R.L. Regulation of nicotinic acetylcholine receptor phosphorylation in rat myotubes by forskolin and cAMP. Proc. Natl. Acad. Sci. 84:1987;6591-6595.
17. Nakayama H., Okuda H., Nakashima T. Phosphorylation of rat brain nicotinic acetylcholine receptor by cAMP-dependent protein kinase in vitro. Mol. Brain Res. 20:1993;171-177.
18. Nakayama H., Okuda H., Nakashima T. In vitro phosphorylation of rat brain nicotinic acetylcholine receptor by cAMP-dependent protein kinase. Ann. N. Y. Acad. Sci. 707:1993;439-442.
19. Ono-Saito N., Niki I., Hidaka H. H-series protein kinase inhibitors and potential clinical applications. Pharmacol. Ther. 82:1999;123-131.
20. Pacheco M.A., Pastoor T.E., Lukas R.J., Wecker L. Characterization of human α4β2 neuronal nicotinic receptors stably transfected in SH-EP1 cells. Neurochem. Res. 26:2001;683-693.
21. Ramamoorthy S., Giovanetti E., Qian Y., Blakely R.D. Phosphorylation and regulation of antidepressant-sensitive serotonin transporters. J. Biol. Chem. 273:1998;2458-2466.
22. Rothhut B., Romano S.J., Vijayaraghavan S., Berg D.K. Post-translational regulation of neuronal acetylcholine receptors stably expressed in a mouse fibroblast cell line. J. Neurobiol. 29:1996;115-125.
23. Schultz C., Vajanaphanich M., Genieser H.-G., Jastorff B., Barrett K.E., Tsien R.Y. Membrane-permeant derivatives of cyclic AMP optimized for high potency, prolonged activity, or rapid reversibility. Mol. Pharmacol. 46:1994;702-708.
24. Swope S.L., Moss S.J., Raymond L.A., Huganir R.L. Regulation of ligand-gated ion channels by protein phosphorylation. Adv. Second Messenger Phosphoprotein Res. 33:1999;49-78.
25. Tzivion G., Avruch J. 14-3-3 proteins: active cofactors in cellular regulation by serine/threonine phosphorylation. J. Biol. Chem. 277:2002;3061-3064.
26. Vijayaraghavan S., Schmid H.A., Halvorsen S.W., Berg D.K. Cyclic AMP-dependent phosphorylation of a neuronal acetylcholine receptor α-type subunit. J. Neurosci. 10:1990;3255-3262.
27. Viseshakul N., Figl A., Lytle C., Cohen B.N. The α4 subunit of rat α4β2 nicotinic receptors is phosphorylated in vivo. Mol. Brain Res. 59:1998;100-104.
28. Wecker L., Guo X., Rycerz A.M., Edwards S.C. Cyclic AMP-dependent protein kinase A (PKA) and protein kinase C phosphorylate sites in the amino acid sequence corresponding to the M3/M4 cytoplasmic domain of α4 neuronal nicotinic receptor subunits. J. Neurochem. 76:2001;711-720.
29. Wecker L., Rogers C.Q. Phosphorylation sites within α4 subunits of α4β2 neuronal nicotinic receptors: a comparison of substrate specificities for cAMP-dependent protein kinase (PKA) and protein kinase C (PKC). Neurochem. Res. 28:2003;431-436.